Supporters of waiver say easing patent restrictions will spur production of low-cost generic vaccines but opponents argue it could erode pharmaceutical companies’ profit incentive to develop new treatments.
South Africa and India have pushed for a TRIPS waiver to temporarily allow states to produce Covid-19 technologies without fear of IP infringement. But it faces pressure from rich countries, who want to protect their pharmaceutical industries.
As US seeks to tackle Chinese technological espionage it does so forgetting its own poaching and rise to global power.
The US-listed firm wants to stop the 21-year-old from using its trademarked product name as a moniker in advertisements for tennis clothing.
Subscribe to our Youtube channel for all latest in-depth, on the ground reporting from around the world.
Copyright © 2021 TRT World.